GMAB vs BBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

GMAB

32.7
AI Score
VS
GMAB Wins

BBIO

30.1
AI Score

Investment Advisor Scores

GMAB

33score
Recommendation
AVOID NEW MONEY

BBIO

30score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric GMAB BBIO Winner
Forward P/E 23.1481 0 Tie
PEG Ratio 8.0603 0 Tie
Revenue Growth 16.1% 192.6% BBIO
Earnings Growth -14.7% 0.0% BBIO
Tradestie Score 32.7/100 30.1/100 GMAB
Profit Margin 17.0% -59.8% GMAB
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED BBIO

Relative Price Performance (Last 90 Days)

GMAB 1M: +40.3% · 3M: +62.0% BBIO 1M: +20.4% · 3M: -2.1%

Current Technical Phase

GMAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (19.4% over 20 days), RSI 60

RSI (14): 60.3 · Price: $51.74

BBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 64.7 · Price: $78.17

Fundamentals Snapshot

Metric GMAB BBIO
Market Cap — —
Forward P/E 29.3 -286.0
Trailing P/E 46.0 —
Revenue (TTM) — —
Revenue Growth 0.2% 1.9%
Gross Margin 0.9% 0.9%
Operating Margin 0.3% -0.4%
EPS 1.17 -3.07
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GMAB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.